Management of Peritoneal Surface Malignancies in Saudi Arabia: An Update

Author:

Helmi Hadeel1ORCID,Alyami Mohammad2ORCID,Bin Traiki Thamer3,Amin Tarek4ORCID,Alzahrani Abdulaziz5,Alnahawi Mamdouh6,Alzahrani Nayef1ORCID

Affiliation:

1. Department of Surgery King Abdulaziz Medical City, Ministry of National Guard Health Affairs Riyadh Saudi Arabia

2. Department of Surgery King Khalid Hospital Najran Saudi Arabia

3. Department of Surgery, College of Medicine King Saud University Riyadh Saudi Arabia

4. Department of Surgical Oncology King Faisal Specialist Hospital & Research Centre Riyadh Saudi Arabia

5. Department of Surgical Oncology King Abdullah Medical City Makkah Saudi Arabia

6. Department of Surgery Almoosa Specialist Hospital Alhasa Saudi Arabia

Abstract

ABSTRACTPeritoneal surface malignancies (PSM) are aggressive and associated with poor prognosis. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) have been used to treat PSM since 1990. In Saudi Arabia, the first HIPEC and pressurized intraperitoneal aerosol chemotherapy (PIPAC) were performed in 2008 and 2019, respectively. With increasing incidences of PSM in Saudi Arabia, the demand for such procedures has grown. This article outlines the status of PSM management in Saudi Arabia and its prospects.

Publisher

Wiley

Reference16 articles.

1. Intra‐Peritoneal Chemo‐Hyperthermia (CHIP): A New Therapy in the Treatment of the Peritoneal Seedings. Preliminary Report;Gilly F. N.;International Surgery,1991

2. Surgical Treatment of Peritoneal Carcinomatosis: 1988 Du Pont Lecture;Sugarbaker P. H.;Canadian Journal of Surgery. Journal canadien de chirurgie,1989

3. Clinical Research Methodologies in Diagnosis and Staging of Patients With Peritoneal Carcinomatosis;Jacquet P.;Cancer Treatment and Research,1996

4. Prognostic Indicators in Peritoneal Carcinomatosis From Gastrointestinal Cancer;Harmon R. L.;International Seminars in Surgical Oncology,2005

5. Pressurised Intraperitoneal Aerosol Chemotherapy: Rationale, Evidence, and Potential Indications;Alyami M.;Lancet Oncology,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3